Reactivation of latent tuberculosis in cynomolgus macaques infected with SIV is associated with early peripheral T cell depletion and not virus load

PLoS ONE

Volumn 5, Issue 3, 2010, Pages

  Diedrich, Collin R ^a   Mattila, Joshua T ^a   Klein, Edwin ^a   Janssen, Chris ^a   Phuah, Jiayao ^a   Sturgeon, Timothy J ^a   Montelaro, Ronald C ^a   Lin, Philana Ling ^b   Flynn, JoAnne L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; GRANULOMA; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LATENT PERIOD; LATENT VIRUS INFECTION; LYMPH NODE; MACACA; MIXED INFECTION; NONHUMAN; OUTCOME ASSESSMENT; POSTPRIMARY TUBERCULOSIS; SIMIAN IMMUNODEFICIENCY VIRUS; T CELL DEPLETION; VIRUS LOAD; ANIMAL; CD4+ T LYMPHOCYTE; COMORBIDITY; CYTOLOGY; FLOW CYTOMETRY; IMMUNE SYSTEM; IMMUNOLOGY; MACACA FASCICULARIS; METABOLISM; METHODOLOGY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; T LYMPHOCYTE;

ANIMALIA; MACACA; MYCOBACTERIUM TUBERCULOSIS; SIMIAN IMMUNODEFICIENCY VIRUS;

GAMMA INTERFERON; VIRUS ANTIBODY;

ANIMALS; ANTIBODIES, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; COMORBIDITY; FLOW CYTOMETRY; GRANULOMA; IMMUNE SYSTEM; INTERFERON-GAMMA; MACACA FASCICULARIS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES; VIRAL LOAD;

EID: 77949758134     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009611     Document Type: Article

References (46)

1. Ulrichs T, Kosmiadi GA, Jorg S, Pradl L, Titukhina M, et al. (2005) Differential organization of the local immune response in patients with active cavitary tuberculosis or with nonprogressive tuberculoma. J Infect Dis 192: 89-97.
2. Harries AD, Dye C (2006) Tuberculosis. Ann Trop Med Parasitol 100: 415-431.
3. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, et al. (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163: 1009-1021.
4. Post FA, Wood R, Pillay GP (1995) Pulmonary tuberculosis in HIV infection: radiographic appearance is related to CD4+ T-lymphocyte count. Tuber Lung Dis 76: 518-521.
5. Mukadi Y, Perriens JH, St Louis ME, Brown C, Prignot J, et al. (1993) Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire. Lancet 342: 143-146.
6. Hanson DL, Chu SY, Farizo KM, Ward JW (1995) Distribution of CD4+ T lymphocytes at diagnosis of acquired immunodeficiency syndrome-defining and other human immunodeficiency virus-related illnesses. The Adult and Adolescent Spectrum of HIV Disease Project Group. Arch Intern Med 155: 1537-1542.
7. Law KF, Jagirdar J, Weiden MD, Bodkin M, Rom WN (1996) Tuberculosis in HIV-positive patients: cellular response and immune activation in the lung. Am J Respir Crit Care Med 153: 1377-1384.
8. Toossi Z (2003) Virological and immunological impact of tuberculosis on human immunodeficiency virus type 1 disease. J Infect Dis 188: 1146-1155.
9. Lawn SD, Butera ST, Shinnick TM (2002) Tuberculosis unleashed: the impact of human immunodeficiency virus infection on the host granulomatous response to Mycobacterium tuberculosis. Microbes Infect 4: 635-646.
10. Nath BM, Schumann KE, Boyer JD (2000) The chimpanzee and other non-human-primate models in HIV-1 vaccine research. Trends Microbiol 8: 426-431.
11. Reimann KA, Parker RA, Seaman MS, Beaudry K, Beddall M, et al. (2005) Pathogenicity of simian-human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early T-lymphocyte responses. J Virol 79: 8878-8885.
12. Silvestri G (2008) AIDS pathogenesis: a tale of two monkeys. J Med Primatol 37 Suppl 2: 6-12.
13. Peruchon S, Chaoul N, Burelout C, Delache B, Brochard P, et al. (2009) Tissue-specific B-cell dysfunction and generalized memory B-cell loss during acute SIV infection. PLoS One 4: e5966.
14. Le Tortorec A, Le Grand R, Denis H, Satie AP, Mannioui K, et al. (2008) Infection of semen-producing organs by SIV during the acute and chronic stages of the disease. PLoS One 3: e1792.
15. Qin S, Sui Y, Murphey-Corb MA, Reinhart TA (2008) Association between decreased CXCL12 and CCL25 expression and increased apoptosis in lymphoid tissues of cynomolgus macaques during SIV infection. J Med Primatol 37 Suppl 2: 46-54.
16. Karlsson I, Malleret B, Brochard P, Delache B, Calvo J, et al. (2007) Dynamics of T-cell responses and memory T cells during primary simian immunodeficiency virus infection in cynomolgus macaques. J Virol 81: 13456-13468.
17. Dioszeghy V, Benlhassan-Chahour K, Delache B, Dereuddre-Bosquet N, Aubenque C, et al. (2006) Changes in soluble factor-mediated CD8+ cell-derived antiviral activity in cynomolgus macaques infected with simian immunodeficiency virus SIVmac251: relationship to biological markers of progression. J Virol 80: 236-245.
18. Lin PL, Rodgers M, Smith L, Bigbee M, Myers A, et al. (2009) Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model. Infect Immun 77: 4631-4642.
19. Lewinsohn DM, Tydeman IS, Frieder M, Grotzke JE, Lines RA, et al. (2006) High resolution radiographic and fine immunologic definition of TB disease progression in the rhesus macaque. Microbes Infect 8: 2587-2598.
20. Croix DA, Capuano S, 3rd, Simpson L, Fallert BA, Fuller CL, et al. (2000) Effect of mycobacterial infection on virus loads and disease progression in simian immunodeficiency virus-infected rhesus monkeys. AIDS Res Hum Retroviruses 16: 1895-1908.
21. Capuano SV, 3rd, Croix DA, Pawar S, Zinovik A, Myers A, et al. (2003) Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection. Infect Immun 71: 5831-5844.
22. Langermans JA, Doherty TM, Vervenne RA, van der Laan T, Lyashchenko K, et al. (2005) Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6. Vaccine 23: 2740-2750.
23. Verreck FA, Vervenne RA, Kondova I, van Kralingen KW, Remarque EJ, et al. (2009) MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques. PLoS One 4: e5264.
24. Lin P, Myers A, Smith L, Bigbee C, Bigbee M, et al. (2010) Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model. Arthritis and Rheumatism 62: 340-50.
25. Safi H, Gormus BJ, Didier PJ, Blanchard JL, Lakey DL, et al. (2003) Spectrum of manifestations of Mycobacterium tuberculosis infection in primates infected with SIV. AIDS Res Hum Retroviruses 19: 585-595.
26. Shen Y, Zhou D, Chalifoux L, Shen L, Simon M, et al. (2002) Induction of an AIDS virus-related tuberculosis-like disease in macaques: a model of simian immunodeficiency virus- mycobacterium coinfection. Infect Immun 70: 869-877.
27. Pawar SN, Mattila JT, Sturgeon TJ, Lin PL, Narayan O, et al. (2008) Comparison of the effects of pathogenic simian human immunodeficiency virus strains SHIV-89.6P and SHIV-KU2 in cynomolgus macaques. AIDS Res Hum Retroviruses 24: 643-654.
28. Leutenegger CM, Higgins J, Matthews TB, Tarantal AF, Luciw PA, et al. (2001) Real-time TaqMan PCR as a specific and more sensitive alternative to the branched-chain DNA assay for quantitation of simian immunodeficiency virus RNA. AIDS Res Hum Retroviruses 17: 243-251.
29. Via LE, Lin PL, Ray SM, Carrillo J, Allen SS, et al. (2008) Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect Immun 76: 2333-2340.
30. Nakata K, Rom WN, Honda Y, Condos R, Kanegasaki S, et al. (1997) Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung. Am J Respir Crit Care Med 155: 996-1003.
31. Vajdy M, Veazey R, Tham I, deBakker C, Westmoreland S, et al. (2001) Early immunologic events in mucosal and systemic lymphoid tissues after intrarectal inoculation with simian immunodeficiency virus. J Infect Dis 184: 1007-1014.
32. Ciccone EJ, Read SW, Mannon PJ, Yao MD, Hodge JN, et al. (2010) Cycling of gut mucosal CD4+ T cells decreases after prolonged anti-retroviral therapy and is associated with plasma LPS levels. Mucosal Immunol 3: 172-81.
33. Sonnenberg P, Glynn JR, Fielding K, Murray J, Godfrey-Faussett P, et al. (2005) How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. J Infect Dis 191: 150-158.
34. Lawn SD, Myer L, Edwards D, Bekker LG, Wood R (2009) Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. Aids 23: 1717-1725.
35. Lucas S, Nelson A Pathogenesis of tuberculosis in human immunodeficiency virus-infected people, in B.R. Bloom (Ed.). Tuberculosis: Pathogenesis, Protection and Control ASM press, Washington DC. pp 503-513.
36. Park IW, He JJ (2009) HIV-1 Nef-mediated inhibition of T cell migration and its molecular determinants. J Leukoc Biol 8: 1171-8.
37. Bezuidenhout J, Roberts T, Muller L, van Helden P, Walzl G (2009) Pleural tuberculosis in patients with early HIV infection is associated with increased TNF-alpha expression and necrosis in granulomas. PLoS One 4: e4228.
38. Hertoghe T, Wajja A, Ntambi L, Okwera A, Aziz MA, et al. (2000) T cell activation, apoptosis and cytokine dysregulation in the (co)pathogenesis of HIV and pulmonary tuberculosis (TB). Clin Exp Immunol 122: 350-357.
39. Hoshino Y, Tse DB, Rochford G, Prabhakar S, Hoshino S, et al. (2004) Mycobacterium tuberculosis-induced CXCR4 and chemokine expression leads to preferential X4 HIV-1 replication in human macrophages. J Immunol 172: 6251-6258.
40. Hoshino Y, Hoshino S, Gold JA, Raju B, Prabhakar S, et al. (2007) Mechanisms of polymorphonuclear neutrophil-mediated induction of HIV-1 replication in macrophages during pulmonary tuberculosis. J Infect Dis 195: 1303-1310.
41. Goletti D, Carrara S, Vincenti D, Giacomini E, Fattorini L, et al. (2004) Inhibition of HIV-1 replication in monocyte-derived macrophages by Mycobacterium tuberculosis. J Infect Dis 189: 624-633.
42. Hoshino Y, Nakata K, Hoshino S, Honda Y, Tse DB, et al. (2002) Maximal HIV-1 replication in alveolar macrophages during tuberculosis requires both lymphocyte contact and cytokines. J Exp Med 195: 495-505.
43. Collins KR, Quinones-Mateu ME, Toossi Z, Arts EJ (2002) Impact of tuberculosis on HIV-1 replication, diversity, and disease progression. AIDS Rev 4: 165-176.
44. Collins KR, Quinones-Mateu ME, Wu M, Luzze H, Johnson JL, et al. (2002) Human immunodeficiency virus type 1 (HIV-1) quasispecies at the sites of Mycobacterium tuberculosis infection contribute to systemic HIV-1 heterogeneity. J Virol 76: 1697-1706.
45. Mankatittham W, Likanonsakul S, Thawornwan U, Kongsanan P, Kittikraisak W, et al. (2009) Characteristics of HIV-infected tuberculosis patients in Thailand. Southeast Asian J Trop Med Public Health 40: 93-103.
46. Lopez-Gatell H, Cole SR, Margolick JB, Witt MD, Martinson J, et al. (2008) Effect of tuberculosis on the survival of HIV-infected men in a country with low tuberculosis incidence. Aids 22: 1869-1873.